|
33 Companies |
|
35 Products |
|
35 Products |
|
38 Mechanisms of Action |
|
1 Trial |
|
827 News |
|
| «12...567891011121314151617» |
- risperidone / Generic mfg., desipramine / Generic mfg.
Enrollment closed: RADIAUS: Risperidone and Desipramine in Alcohol Use and Schizophrenia (clinicaltrials.gov) - Jun 18, 2014
P2, N=40, Active, not recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting --> Active, not recruiting
- naltrexone / Generic mfg.
Trial primary completion date: Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS)) (clinicaltrials.gov) - Jun 17, 2014
P=N/A, N=160, Recruiting, Sponsor: University of Michigan
Recruiting --> Active, not recruiting Trial primary completion date: May 2015 --> May 2017
- Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
Trial primary completion date: Naltrexone & SSRI in Alcoholics With Depression/PTSD (clinicaltrials.gov) - Jun 17, 2014
P3, N=120, Active, not recruiting, Sponsor: Elizabeth Ralevski
Trial primary completion date: May 2015 --> May 2017 Trial primary completion date: Aug 2013 --> Oct 2014
- ||| GSK1521498 / GSK
Trial completion: To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers (clinicaltrials.gov) - Jun 17, 2014
P1, N=57, Completed, Sponsor: GlaxoSmithKline
Trial primary completion date: Aug 2013 --> Oct 2014 Active, not recruiting --> Completed
- | metadoxine / Generic mfg.
New P4 trial: Metadoxine as a Therapy for Severe Alcoholic Hepatitis (clinicaltrials.gov) - Jun 13, 2014
P4, N=140, Active, not recruiting, Sponsor: Hospital General de Mexico
- New P2 trial: Medication Development in Alcoholism: Investigating PPAR Agonists (clinicaltrials.gov) - Jun 4, 2014
P2, N=50, Recruiting, Sponsor: The Scripps Research Institute
- |||| BTRX-246040 / BlackThorn Therap
Trial completion: A Study of LY2940094 in Participants With Alcohol Dependency (clinicaltrials.gov) - Jun 4, 2014
P2, N=130, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial suspension: SETH-HA: Liver Transplantation in Alcoholic Hepatitis (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=40, Suspended, Sponsor: Sociedad Española de Trasplante Hepático
Active, not recruiting --> Completed Not yet recruiting --> Suspended
- Enrollment open: Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (clinicaltrials.gov) - May 30, 2014
P=N/A, N=1000, Recruiting, Sponsor: Swiss Tropical & Public Health Institute
Not yet recruiting --> Suspended Not yet recruiting --> Recruiting
- GSK1521498 / GSK
Enrollment change: GSK1521498 Alcohol Interaction Study (clinicaltrials.gov) - May 28, 2014
P1, N=1, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting N=28 --> 1
- Clinical: Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal (clinicaltrials.gov) - May 22, 2014
P=N/A, N=180, Not yet recruiting, Sponsor: Centre Hospitalier Esquirol
- Trial primary completion date: Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence (clinicaltrials.gov) - May 20, 2014
P=N/A, N=60, Recruiting, Sponsor: University of Virginia
N=28 --> 1 Trial primary completion date: Dec 2013 --> Dec 2015
- Trial completion date: Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence (clinicaltrials.gov) - May 20, 2014
P=N/A, N=60, Recruiting, Sponsor: University of Virginia
Trial primary completion date: Dec 2013 --> Dec 2015 Trial completion date: Dec 2014 --> Jul 2016
- Enrollment open: Tailored Mobile Text Messaging to Reduce Problem Drinking (clinicaltrials.gov) - May 19, 2014
P=N/A, N=300, Recruiting, Sponsor: Research Foundation for Mental Hygiene, Inc.
Trial completion date: Dec 2014 --> Jul 2016 Not yet recruiting --> Recruiting
- Trial primary completion date: RiScA: Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication (clinicaltrials.gov) - May 19, 2014
P=N/A, N=394, Completed, Sponsor: Technische Universität Dresden
Not yet recruiting --> Recruiting Trial primary completion date: Jan 2013 --> May 2013
- Trial completion date: RiScA: Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication (clinicaltrials.gov) - May 19, 2014
P=N/A, N=394, Completed, Sponsor: Technische Universität Dresden
Trial primary completion date: Jan 2013 --> May 2013 Trial completion date: Dec 2013 --> Jun 2013
- Enrollment change: RiScA: Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication (clinicaltrials.gov) - May 19, 2014
P=N/A, N=394, Completed, Sponsor: Technische Universität Dresden
Trial completion date: Dec 2013 --> Jun 2013 N=500 --> 394
- Trial completion: RiScA: Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication (clinicaltrials.gov) - May 19, 2014
P=N/A, N=394, Completed, Sponsor: Technische Universität Dresden
N=500 --> 394 Recruiting --> Completed
- Clinical: Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease (clinicaltrials.gov) - May 14, 2014
P=N/A, N=856, Not yet recruiting, Sponsor: Institute of Liver and Biliary Sciences, India
- Trial primary completion date: Project SERVE: Post Deployment Functioning (clinicaltrials.gov) - May 11, 2014
P=N/A, N=309, Active, not recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Trial primary completion date: Sep 2013 --> Jun 2014
- Trial primary completion date: Integrated Collaborative Care for Substance Use Disorders (clinicaltrials.gov) - May 8, 2014
P=N/A, N=400, Not yet recruiting, Sponsor: RAND
Trial primary completion date: Sep 2013 --> Jun 2014 Trial primary completion date: Jan 2017 --> Apr 2017
- Trial completion date: Integrated Collaborative Care for Substance Use Disorders (clinicaltrials.gov) - May 8, 2014
P=N/A, N=400, Not yet recruiting, Sponsor: RAND
Trial primary completion date: Jan 2017 --> Apr 2017 Trial completion date: Jan 2018 --> Apr 2018
- Trial initiation date: Integrated Collaborative Care for Substance Use Disorders (clinicaltrials.gov) - May 8, 2014
P=N/A, N=400, Not yet recruiting, Sponsor: RAND
Trial completion date: Jan 2018 --> Apr 2018 Initiation date: Aug 2013 --> Mar 2014
- GSK1521498 / GSK
Enrollment closed: To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers (clinicaltrials.gov) - May 7, 2014
P1, N=48, Active, not recruiting, Sponsor: GlaxoSmithKline
Initiation date: Aug 2013 --> Mar 2014 Recruiting --> Active, not recruiting
- naltrexone / Generic mfg.
Trial completion date: Naltrexone Treatment for Alcoholic Women (clinicaltrials.gov) - May 5, 2014
P4, N=160, Completed, Sponsor: Yale University
Recruiting --> Active, not recruiting Trial completion date: Feb 2001 --> Dec 2000
- naltrexone / Generic mfg.
Enrollment change: Naltrexone Treatment for Alcoholic Women (clinicaltrials.gov) - May 5, 2014
P4, N=160, Completed, Sponsor: Yale University
Trial completion date: Feb 2001 --> Dec 2000 N=120 --> 160
- || naltrexone / Generic mfg.
Trial primary completion date, Adherence: AGATE: Adaptive Goal-Directed Adherence Tracking and Enhancement (clinicaltrials.gov) - May 4, 2014
P2, N=136, Completed, Sponsor: Talaria, Inc
N=120 --> 160 Trial primary completion date: Jun 2012 --> Feb 2013
- || naltrexone / Generic mfg.
Trial completion date, Adherence: AGATE: Adaptive Goal-Directed Adherence Tracking and Enhancement (clinicaltrials.gov) - May 4, 2014
P2, N=136, Completed, Sponsor: Talaria, Inc
Trial primary completion date: Jun 2012 --> Feb 2013 Trial completion date: Oct 2012 --> Feb 2013
- ||| naltrexone / Generic mfg.
Enrollment change, Adherence: AGATE: Adaptive Goal-Directed Adherence Tracking and Enhancement (clinicaltrials.gov) - May 4, 2014
P2, N=136, Completed, Sponsor: Talaria, Inc
Trial completion date: Oct 2012 --> Feb 2013 N=105 --> 136
- |||| naltrexone / Generic mfg.
Trial completion, Adherence: AGATE: Adaptive Goal-Directed Adherence Tracking and Enhancement (clinicaltrials.gov) - May 4, 2014
P2, N=136, Completed, Sponsor: Talaria, Inc
N=105 --> 136 Recruiting --> Completed
- topiramate / Generic mfg.
Enrollment closed: Topiramate to Aid Smoking Cessation in Alcohol Dependent Men (clinicaltrials.gov) - May 4, 2014
P2, N=150, Active, not recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||| Trial primary completion date: Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure (clinicaltrials.gov) - May 1, 2014
P3, N=200, Recruiting, Sponsor: Vital Therapies, Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Aug 2014 --> Dec 2014
- ||| Trial completion date: Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure (clinicaltrials.gov) - May 1, 2014
P3, N=200, Recruiting, Sponsor: Vital Therapies, Inc.
Trial primary completion date: Aug 2014 --> Dec 2014 Trial completion date: Nov 2014 --> Mar 2015
- Trial termination, Surgery: ITBCHIR: Efficacy of a Brief Alcohol Intervention for Non Dependant Alcohol-misusing Patients Undergoing a Scheduled Surgery (clinicaltrials.gov) - Apr 29, 2014
P3, N=3, Terminated, Sponsor: Rennes University Hospital
Trial completion date: Nov 2014 --> Mar 2015 Recruiting --> Terminated
- Enrollment change, Surgery: ITBCHIR: Efficacy of a Brief Alcohol Intervention for Non Dependant Alcohol-misusing Patients Undergoing a Scheduled Surgery (clinicaltrials.gov) - Apr 29, 2014
P3, N=3, Terminated, Sponsor: Rennes University Hospital
Recruiting --> Terminated N=300 --> 3
- Clinical: CARRII: Contraception and Alcohol Risk Reduction Internet Intervention Randomized Trial (clinicaltrials.gov) - Apr 28, 2014
P=N/A, N=70, Not yet recruiting, Sponsor: University of Virginia
- Clinical: Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (clinicaltrials.gov) - Apr 28, 2014
P=N/A, N=1000, Not yet recruiting, Sponsor: Swiss Tropical & Public Health Institute
- ||| BTRX-246040 / BlackThorn Therap
Enrollment closed: A Study of LY2940094 in Participants With Alcohol Dependency (clinicaltrials.gov) - Apr 24, 2014
P2, N=130, Active, not recruiting, Sponsor: Eli Lilly and Company
N=300 --> 3 Recruiting --> Active, not recruiting
- ||||| Trial initiation date: To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure (clinicaltrials.gov) - Apr 22, 2014
P3, N=120, Recruiting, Sponsor: Vital Therapies, Inc.
Recruiting --> Active, not recruiting Initiation date: Dec 2013 --> Apr 2014
- |||||| Enrollment open: To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure (clinicaltrials.gov) - Apr 22, 2014
P3, N=120, Recruiting, Sponsor: Vital Therapies, Inc.
Initiation date: Dec 2013 --> Apr 2014 Not yet recruiting --> Recruiting
- Enrollment open: Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis (clinicaltrials.gov) - Apr 16, 2014
P=N/A, N=56, Recruiting, Sponsor: Institute of Liver and Biliary Sciences, India
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | sodium valproate / Generic mfg., divalproex sodium XR / Generic mfg.
Enrollment open: Treatment Strategy for Alcohol Use Disorders in Veterans With TBI (clinicaltrials.gov) - Apr 15, 2014
P3, N=70, Recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- citalopram / Generic mfg.
Enrollment change: STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse (clinicaltrials.gov) - Apr 8, 2014
P4, N=674, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Recruiting N=60 --> 674
- Enrollment change: Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER) (clinicaltrials.gov) - Apr 8, 2014
P=N/A, N=3694, Completed, Sponsor: University of Michigan
N=60 --> 674 N=3000 --> 3694
- Trial completion: Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER) (clinicaltrials.gov) - Apr 8, 2014
P=N/A, N=3694, Completed, Sponsor: University of Michigan
N=3000 --> 3694 Active, not recruiting --> Completed
- Enrollment open: Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP Study (clinicaltrials.gov) - Apr 6, 2014
P=N/A, N=80, Recruiting, Sponsor: Brugmann University Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults (clinicaltrials.gov) - Apr 3, 2014
P1, N=38, Completed, Sponsor: St. Louis University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Enrollment closed: Efficacy Trial of Warrior Check-Up (clinicaltrials.gov) - Apr 2, 2014
P2, N=240, Active, not recruiting, Sponsor: University of Washington
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment open: LeAD_P4: Project 4: Acute Effects of Alcohol on Learning and Habitization in Healthy Young Adults (clinicaltrials.gov) - Apr 1, 2014
P=N/A, N=80, Recruiting, Sponsor: Technische Universität Dresden
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- naltrexone / Generic mfg.
Trial termination: Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers (clinicaltrials.gov) - Mar 31, 2014
P4, N=2, Terminated, Sponsor: Centre for Addiction and Mental Health
Not yet recruiting --> Recruiting Recruiting --> Terminated; Recruitment proved to be extremely difficult.